08 Feb MediLynx Chosen to Participate in NIH Study of Efficacy of Mobile Cardiac Monitoring for Patients
Posted at 06:00h
in Press Releases
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]PLANO, Texas, Feb. 8, 2022 /PRNewswire/ -- MediLynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics™), a national remote monitoring provider and technology leader in deep learning artificial intelligence, today announced a groundbreaking partnership with the National Heart, Lung, and Blood Institute...
